Skip to main content

Advertisement

SpringerLink
Log in

Intravitreal bevacizumab and feeder vessel laser treatment for a posteriorly located retinal capillary hemangioma

  • Case Report
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Retinal capillary hemangioma (RCH) is strongly associated with von Hippel–Lindau (VHL) disease. Treatment of this sight-threatening condition is often unsatisfactory despite multiple treatment options available. We here describe an interesting case of a 50-year-old male with RCH located in the perifoveal region of the left eye. Subretinal bleed, exudation, and macular edema resulted in progressive deterioration of visual acuity. Fundus photography, fluorescein angiography, and optical coherence tomography (OCT) were used to serially monitor the lesion. After ruling out systemic lesions of VHL disease, the patient was subjected to direct laser photocoagulation of the lesion which resulted in further loss in vision with increase in bleed and exudation. Subsequently, the patient was given 2 monthly intravitreal injections of bevacizumab followed by laser photocoagulation of feeder arteriole. This combination therapy resulted in resolution of exudation, bleed, and macular edema with improvement in visual acuity. Thus, vision-threatening RCH may be safely and effectively treated by means of a combination therapy comprising of intravitreal bevacizumab and feeder vessel treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. McCabe CM, Flynn HW Jr, Shields CL, Shields JA, Regillo CD, McDonald R et al (2000) Juxtapapillary retinal capillary hemangiomas: clinical features and visual outcomes. Ophthalmology 107:2240–2249

    Article  CAS  PubMed  Google Scholar 

  2. Webster AR, Maher ER, Moore AT (1999) Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol 117:371–378

    Article  CAS  PubMed  Google Scholar 

  3. Ridley M, Green J, Johnson G (1986) Retinal angiomatosis: the ocular manifestations of von Hippel-Lindau disease. Can J Ophthalmol 21:276–283

    CAS  PubMed  Google Scholar 

  4. Wong WT, Agron E, Coleman HR, Tran T, Reed GF, Csaky K et al (2008) Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease. Ophthalmology 115:181–188

    Article  PubMed  Google Scholar 

  5. Meyer-Schwickerath G (1961) The preservation of vision by treatment of intraocular tumors with light coagulation. Arch Ophthalmol 66:458–466

    Article  CAS  PubMed  Google Scholar 

  6. Annesley WJ, Leonard BC, Shields JA, Tasman WS (1977) Fifteen year review of treated cases of retinal angiomatosis. Trans Am Acad Ophthalmol Otolaryngol 83:446–453

    Google Scholar 

  7. Aiello LP, George DJ, Cahill MT et al (2002) Rapid and durable recovery of visual function in a patient with von Hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor SU5416. Ophthalmology 109:1745–1751

    Article  PubMed  Google Scholar 

  8. Ach T, Thiemeyer D, Hoeh AE, Beate K, Dithmar S (2010) Intravitreal bevacizumab for retinal capillary hemangioma: long term results. Acta Ophthalmol 88:e137–e138

    Article  PubMed  Google Scholar 

  9. von Buelow M, Pape S, Hoerauf H (2007) Systemic bevacizumab treatment of a juxtapapillary retinal haemangioma. Acta Ophthalmol Scand 85:114–116

    Article  Google Scholar 

  10. Welch RB (1970) von Hippel-Lindau disease: the recognition and treatment of early angiomatosis retinae and the use of cryosurgery as an adjunct to therapy. Trans Am Ophthalmol Soc 68:367–424

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Shields JA (1993) Response of retinal capillary hemangioma to cryotherapy. Arch Ophthalmol 111:551

    Article  CAS  PubMed  Google Scholar 

  12. Aaberg TM Jr, Aaberg TM Sr, Martin DF, Gilman JP, Myles R (2005) Three cases of large retinal capillary hemangiomas treated with verteporfin and photodynamic therapy. Arch Ophthalmol 123:328–332

    Article  PubMed  Google Scholar 

  13. Blodi CF, Russell SR, Pulido JS, Folk JC (1990) Direct and feeder vessel photocoagulation of retinal angiomas with dye yellow laser. Ophthalmology 97:791–795

    Article  CAS  PubMed  Google Scholar 

  14. Gaudric A, Krivosic V, Duguid G, Massin P, Giraud S, Richard S (2011) Vitreoretinal surgery for severe retinal capillary hemangiomas in von Hippel-Lindau disease. Ophthalmology 118:142–149

    Article  PubMed  Google Scholar 

  15. Singh AD, Nouri M, Shields CL, Shields JA, Perez N (2002) Treatment of retinal capillary hemangioma. Ophthalmology 109:1799–1806

    Article  PubMed  Google Scholar 

  16. Schmidt-Erfurth UM, Kusserow C, Barbazetto IA, Laqua H (2002) Benefits and complications of photodynamic therapy of papillary capillary hemangiomas. Ophthalmology 109:1256–1266

    Article  PubMed  Google Scholar 

  17. Bhattacharjee H, Deka H, Deka S, Barman MJ, Mazumdar M, Medhi J (2010) Verteporfin photodynamic therapy of retinal capillary hemangioblastoma in von Hippel-Lindau disease. Indian J Ophthalmol 58:73

    Article  PubMed  PubMed Central  Google Scholar 

  18. Haining WM, Zweifach PH (1967) Fluorescein angiography in von Hippel-Lindau disease. Arch Ophthalmol 78:475–479

    Article  CAS  PubMed  Google Scholar 

  19. Archer DM, Deutman A, Ernest JT et al (1973) Arteriovenous communications of the retina. Am J Ophthalmol 75:224–241

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, USA

    Aniruddha Agarwal

  2. Department of Ophthalmology, Advanced Eye Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh, 160012, India

    Neha Kumari & Ramandeep Singh

Authors
  1. Aniruddha Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neha Kumari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ramandeep Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ramandeep Singh.

Ethics declarations

Conflict of interest

No conflicting relationship exists for any author.

Disclosure

Authors have no financial disclosure or any proprietary interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agarwal, A., Kumari, N. & Singh, R. Intravitreal bevacizumab and feeder vessel laser treatment for a posteriorly located retinal capillary hemangioma. Int Ophthalmol 36, 747–750 (2016). https://doi.org/10.1007/s10792-016-0183-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-016-0183-x

Keywords

Search

Navigation